Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$PBYI Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.16 up 33.33% YoY • Reported revenue of $56.5M up 7.75% YoY • Puma Biotechnology raised its full year 2026 guidance, now anticipating net product revenue of $205-$209 million, total revenue of $224-$231 million, and net income in the range of $17-$20 million.
2

Price since post

Full Details

Advertisement|Remove ads.